2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.
about
First-generation versus second-generation drug-eluting stents in current clinical practice: updated evidence from a comprehensive meta-analysis of randomised clinical trials comprising 31 379 patientsOutcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials.Coronary stent thrombosis: current insights into new drug-eluting stent designsSuccinobucol-eluting stents increase neointimal thickening and peri-strut inflammation in a porcine coronary modelSafety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis.Current and future drug-eluting coronary stent technology.Restenosis after PCI. Part 2: prevention and therapy.One-year clinical outcomes of ultra long apollo polymer-based Paclitaxel-eluting stents in patients with complex, long coronary artery lesions.Endothelialization of implanted cardiovascular biomaterial surfaces: the development from in vitro to in vivo.Choosing the right coronary stent in the modern era.Long-term (2-5 years) adverse clinical outcomes associated with ZES versus SES, PES and EES: A Meta-Analysis.Heme Oxygenases in Cardiovascular Health and Disease.Polymer-Free Drug-Coated Coronary Stents in Patients with Stable Coronary Artery Disease at High Bleeding Risk.Preliminary Evaluation of Clinical and Angiographic Outcomes with Biodegradable Polymer Coated Sirolimus-Eluting Stent in De Novo Coronary Artery Disease: Results of the MANIPAL-FLEX Study.Polymer-free dual drug-eluting stents evaluated in a porcine model.A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the DiabeDES IV randomized angiography trial).Controlled drug release from antibiotic-loaded layered double hydroxide coatings on porous titanium implants in a mouse model.Three-Year Clinical Outcomes of a Polymer-Free Paclitaxel-Eluting Microporous Stent in Real-World Practice: Final Results of the Safety and Efficacy Registry of the Yinyi Stent (SERY-I).Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings.One-year clinical outcome of a randomized trial of polymer-free paclitaxel-eluting stents versus biodegradable polymer-based rapamycin-eluting stents in patients with coronary heart disease.One-year outcomes of consecutive patients treated by Endeavor zotarolimus and Resolute zotarolimus stents: the impact of polymer coating in drug-eluting stent technology.Comparison of 2-year clinical outcomes between zotarolimus-, sirolimus-, and paclitaxel-eluting stents in real life clinical practice.Randomized comparison of the Nobori biolimus A9-eluting stent with the sirolimus-eluting stent in patients with stenosis in native coronary arteries.Zotarolimus-eluting vs. sirolimus-eluting coronary stents in patients with and without acute coronary syndromes: a SORT OUT III substudy.Polymer-free versus permanent polymer drug eluting stents in coronary artery disease: A meta-analysis of 10 RCTs with 6575 patients.
P2860
Q28543594-9C0531DB-35F9-4A7D-9754-468CD20DB5AAQ36154232-B65FF605-9819-442C-89DD-EFF2BED24B9CQ36514842-15BA61E0-029D-427F-8808-348C339B680EQ36693115-690EAF63-7823-42FA-9141-F2318F76DCE5Q37284036-3C7C5C86-187E-4417-806B-6F6A00626DFDQ37868581-EBEACAF4-4A8A-4455-84F1-C6E50EC47600Q37944416-A7561938-4228-4C2A-BAFB-D940412BD8D9Q38052908-6F173E10-9FCF-481C-B5D6-484EA08511DFQ38163509-B9C49EA8-0CA4-4851-85E2-98FC83BF8568Q38194095-C23D9002-051C-44C0-BD6D-F11F3D6C3431Q38651885-BEC89834-7BEB-403E-99CE-C801B0398B0DQ38823562-90F6A03B-71C2-4042-941B-0DE6198021B8Q38968542-91ED7786-5FE0-4987-9D58-A85F15E2685CQ39420300-85028949-50D5-4B9B-B88D-DE9E9D9357BAQ41431522-3BF7749B-73DC-4DC5-804F-C2CF1BD5BB55Q41498845-1908D551-AD17-4015-9C94-ED36B9A4DEBAQ41688660-FB863D36-F4AD-450E-8ADA-2E562828F5E2Q41967692-9D9368FF-C057-4A8C-9DD3-59834DE0CCE5Q42133869-EE98D8EE-F510-43A6-91CE-E61C259915FDQ44305034-C0866AD7-008F-4AED-B996-0D31F46B48A7Q44485517-D3915B96-4425-497E-9007-D2D8B82BC5B7Q44517017-AAA5B3D2-9E75-42B8-86D0-078920990E4CQ46005297-F351A3B6-B265-4F6F-BC8E-50F7F5A8E0F4Q46496790-5933F04D-3A21-49C7-A33C-107BB63091FDQ51009195-164FC3B7-F3B2-4BBF-B76C-7A2B5BF311AA
P2860
2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
2-year clinical and angiograph ...... orrected] drug-eluting stents.
@en
2-year clinical and angiograph ...... orrected] drug-eluting stents.
@nl
type
label
2-year clinical and angiograph ...... orrected] drug-eluting stents.
@en
2-year clinical and angiograph ...... orrected] drug-eluting stents.
@nl
prefLabel
2-year clinical and angiograph ...... orrected] drug-eluting stents.
@en
2-year clinical and angiograph ...... orrected] drug-eluting stents.
@nl
P2093
P50
P1476
2-year clinical and angiograph ...... orrected] drug-eluting stents.
@en
P2093
ISAR-TEST-2 Investigators
Jürgen Pache
Katrin A Birkmeier
Klaus Tiroch
Melchior Seyfarth
Steffen Massberg
Susanne Pinieck
P304
P356
10.1016/J.JACC.2010.03.020
P407
P577
2010-04-22T00:00:00Z